Recommended patient information sheet on the impact of haematopoietic cell transplantation on sexual functioning and sexuality.
communication
haematopoietic cell transplantation
patient information
sexual function
sexuality
Journal
Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
04
2019
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
Sexual concerns are common after haematopoietic cell transplantation (HCT). Exposure to total body irradiation (TBI), alkylating agent and graft versus host disease (GvHD) can all affect sexual function, leading to problems in sexual desire, arousal and the orgasm phase of the sexual response cycle. In high-risk haematological malignancies, such as acute leukaemia and myelodysplastic syndromes, HCT often offers the highest chance for long-term survival. In addition, these haematological diseases and HCT can have an impact on body image, self-esteem, (sexual) relationship and psychosocial factors, all of which are able to affect sexuality and sexual function. Five years post HCT, 80% of the female survivors and 46% of the male survivors report sexual dysfunction. It has been shown that these patients cope better after having discussed sexual health. While healthcare providers (HCPs) have the responsibility to address sexual issues, it has been demonstrated that 48%-82% HCT recipients reported not having discussed sexual issues with their HCPs and that only one-third of the HCPs routinely discussed sexual issues with their patients. HCPs describe a lack of knowledge and being uncomfortable with the topic as the most important reasons for not addressing sexual functioning. Even so, it would help >90% HCPs if the patient initiated discussing sexual issues. However, to empower patients addressing sexual issues, adequate comprehensive patient information is needed. In an effort to better meet the patients' need, a patient information sheet: 'Information for patients undergoing Hematopoietic Cell Transplantation: the impact of the disease and treatment on sexual function and sexuality', has been created. In this review, we describe what is known about the impact of HCT on sexual function and briefly the management of sexual problems.
Identifiants
pubmed: 32010211
doi: 10.3332/ecancer.2019.987
pii: can-13-987
pmc: PMC6974367
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
987Informations de copyright
© the authors; licensee ecancermedicalscience.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Sex Med Rev. 2019 Jul;7(3):464-475
pubmed: 30803919
Sex Disabil. 2016;34(4):367-388
pubmed: 27881887
Clin J Oncol Nurs. 2004 Feb;8(1):43-7
pubmed: 14983763
J Cancer. 2012;3:217-25
pubmed: 22606211
Hum Reprod Update. 2001 Jul-Aug;7(4):363-9
pubmed: 11476348
Bone Marrow Transplant. 2012 May;47(5):716-24
pubmed: 21874054
J Cancer Educ. 2017 Dec;32(4):681-689
pubmed: 27278129
Support Care Cancer. 2018 Jun;26(6):1699-1701
pubmed: 29502153
J Clin Nurs. 2013 Dec;22(23-24):3503-12
pubmed: 24003940
Hematology Am Soc Hematol Educ Program. 2005;:523-7
pubmed: 16304430
Rev Bras Hematol Hemoter. 2012;34(2):109-33
pubmed: 23049402
Cancer. 2015 Dec 1;121(23):4124-31
pubmed: 26372459
J Clin Oncol. 2010 Nov 10;28(32):4831-41
pubmed: 20458029
J Sex Med. 2017 Sep;14(9):1104-1115
pubmed: 28781213
Arch Sex Behav. 2016 Jan;45(1):133-44
pubmed: 25624001
Hematology Am Soc Hematol Educ Program. 2010;2010:248-54
pubmed: 21239801
J Clin Endocrinol Metab. 2015 Aug;100(8):3172-82
pubmed: 26000545
Psychooncology. 2012 Jun;21(6):594-601
pubmed: 21394821
Bone Marrow Transplant. 2017 Jun;52(6):803-810
pubmed: 28067883
Hematol Oncol. 2015 Jun;33(2):85-98
pubmed: 24811073
Lancet. 2013 Nov 30;382(9907):1817-29
pubmed: 24286787
J Clin Oncol. 2005 Oct 20;23(30):7555-64
pubmed: 16234521
Blood. 2013 Dec 5;122(24):3973-81
pubmed: 24159171
Ann Oncol. 2006 Sep;17(9):1428-33
pubmed: 16831852
Cancer Nurs. 2015 Mar-Apr;38(2):99-110
pubmed: 25692735
J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59
pubmed: 20525905
J Clin Oncol. 2012 Jan 20;30(3):291-9
pubmed: 22184372
Cancer J. 2009 Jan-Feb;15(1):74-7
pubmed: 19197178
Bone Marrow Transplant. 2007 Apr;39(8):491-6
pubmed: 17322932
J Sex Med. 2010 Apr;7(4 Pt 2):1598-607
pubmed: 20388160
Bone Marrow Transplant. 2014 Feb;49(2):292-8
pubmed: 24096825
J Sex Med. 2016 Feb;13(2):153-67
pubmed: 26953830
Biol Blood Marrow Transplant. 2013 Nov;19(11):1574-80
pubmed: 23962394
Anticancer Res. 2015 Jan;35(1):13-7
pubmed: 25550529
J Sex Med. 2013 Nov;10(11):2658-70
pubmed: 22846467
Int J Womens Health. 2018 Jul 31;10:387-395
pubmed: 30104904
Blood. 2008 Feb 1;111(3):989-96
pubmed: 17878404
Bone Marrow Transplant. 2000 Jun;25(11):1185-9
pubmed: 10849531
Bone Marrow Transplant. 2018 Mar;53(3):235-245
pubmed: 29247220
Eur Urol. 2005 Jan;47(1):80-5; discussion 85-6
pubmed: 15582253